Skip to main content
. 2019 Jul 11;9(7):e027971. doi: 10.1136/bmjopen-2018-027971

Table 2.

Curricular coverage, school years and the course of learning topics for tobacco cessation training in responding pharmacy schools in Japan

Topics Model Core Curriculum Year, M (IQR) Respondents, n=52 (%)
Total Core requisite Elective Elective (non-credit)
Basic knowledge of tobacco cessation education
1 Population-based trends of tobacco use in Japan Related 1) 3 (2–3) 56 50 6 0
2 Health-related problems of tobacco use Related 3 (2–3) 60 54 6 0
3 Health-related problems of secondhand smoke Related 3 (2–3) 56 48 8 0
4 Forms of tobacco used in Japan None 3 (3–5) 14 8 4 2
5 Pharmacological effects of nicotine Listed 2) 3 (2–3) 65 62 4 0
6 Principles of nicotine addiction Listed 3 (3–3) 52 50 2 0
7 Aids for cessation (dosing, side effects, etc) Listed 4 (3–4) 46 40 6 0
8 Drug interactions associated with smoking Listed 3 (3–4) 44 42 2 0
9 Withdrawal effects and health benefits of tobacco cessation None 4 (3–4) 39 35 4 0
Practical skills for tobacco cessation education
1 The 5 As None 4 (3–5) 15 12 2 2
2 The 5 Rs None 4 (3–5) 15 12 2 2
3 The brief intervention model (ask, advise and refer) None 5 (4–6) 10 6 2 2
4 Tobacco user’s readiness to quit smoking None 4 (3–5) 14 12 2 0
5 Cognitive and behavioural strategies for quitting None 4 (2–5) 10 8 0 2
6 Motivation interview for quitting None 4 (2–5) 10 8 0 2
7 Counsel patients on proper use of the aids for cessation Related 3) 4 (3–4) 19 15 2 2
8 The daily costs of the aids for cessation compared with cigarette smoking None 4 (2–6) 15 10 4 2
9 Tailored strategies to assist patients with quitting and following-up based on role-playing scenarios None 5 (3–6) 10 6 2 2
10 Health effects of new tobacco products, including heated tobacco products Related 4) 3 (1–5) 14 10 4 0

Model Core Curriculum category (number: title):

1) D-(2)−3: Lifestyle related Diseases and their prevention.

2) E2-(4): Drugs used for the treatment of Respiratory and digestive tract disorders.

3) E2-(9): Over-the-counter and behind-the-counter drugs and self-medication.

 F2-(4): Professional attitudes and behaviours of practice, patient education and counselling.

 F-(5)−3: Role of pharmacists in primary care and self-medication.

4) F-(5)−2: Advancing pharmacy health literacy in the community.